Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Different parts of the body have unique immune characteristics in their skin.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

A child with Sweet syndrome was found to have chronic granulomatous disease and improved with treatment.

The nodule was a benign cutaneous lymphadenoma, not cancer, and was successfully removed.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

Cyclosporine effectively treated a woman's stubborn skin condition.

BTNL2 helps protect hair follicles from immune attacks.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

The scalp's microorganisms significantly affect hair health and disease.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Angelica sinensis helps repair and regenerate the thymus in mice.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

Biological factors are crucial for developing new hair restoration treatments.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.